Brief: Gi Innovation-Lanova Medicines Signs MoU For Gi-102 + Adc Pancreatic Cancer Combination Therapy

GI Innovation

22/01/2025 14:30

Jan 22 (Reuters) - GI Innovation Inc  358570.KQ :
    * GI INNOVATION-LANOVA MEDICINES SIGNS MOU FOR GI-102 + ADC
PANCREATIC CANCER COMBINATION THERAPY

Source text:  ID:nPnYdtMMa 
Further company coverage:  358570.KQ